About LYNPARZA
LYNPARZA is a company based in Gaithersburg (United States) founded in 2014. It operates as a B2C. LYNPARZA operates in a competitive market with competitors including Resilience, The Blue Box, MyBCTeam, Breast Advocate and DearMamma, among others.
Apps and channels of LYNPARZA
its YouTube channel AstraZeneca US has 86 subscribers and 30 videos.
Videos from LYNPARZA
The most watched videos on LYNPARZA's YouTube channel, AstraZeneca US (86 subscribers). Click a video to play it here.
More on AstraZeneca US.
Competitors of LYNPARZA
LYNPARZA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Resilience, The Blue Box, MyBCTeam, Breast Advocate and DearMamma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| resilience.care | 2021 | Paris, France | $77M | – | A digital solution is provided for remote oncology monitoring. | |
| thebluebox.tech | 2020 | Irvine, United States | $4.06M | – | Breast cancer biomarkers are monitored via smart device and app. | |
| mybcteam.com | 2012 | San Francisco, United States | – | 55 | Social network providing support, information, and connections for breast cancer patients. | |
| breastadvocateapp.com | 2016 | San Antonio, United States | – | – | Offers evidence-based guidance on breast cancer surgery and reconstruction via app. | |
| dearmamma.org | 2006 | Affoltern Am Albis, Switzerland | – | – | Provides an app with tools for managing breast cancer. |
Detailed competitors of LYNPARZA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lynparza
Complete news archive for LYNPARZA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to LYNPARZA
10 companies that operate in the same segment as LYNPARZA (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LYNPARZA
LYNPARZA was founded in 2014.
LYNPARZA is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
LYNPARZA delivers an online platform for managing cancer in women, focusing on providing healthcare solutions, medical services, online platforms, and cancer management. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
LYNPARZA's top competitors include Resilience, The Blue Box and MyBCTeam.